These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10443689)

  • 21. Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture.
    Lawnicka H; Stepień H; Wyczółkowska J; Kolago B; Kunert-Radek J; Komorowski J
    Biochem Biophys Res Commun; 2000 Feb; 268(2):567-71. PubMed ID: 10679244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
    Avramis IA; Kwock R; Avramis VI
    Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenylacetate: a novel nontoxic inducer of tumor cell differentiation.
    Samid D; Shack S; Sherman LT
    Cancer Res; 1992 Apr; 52(7):1988-92. PubMed ID: 1372534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene.
    Suzuki K; Mori A; Saito J; Moriyama E; Ullianich L; Kohn LD
    Endocrinology; 1999 Nov; 140(11):5422-30. PubMed ID: 10537174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation.
    Blaauwgeers HG; Holtkamp GM; Rutten H; Witmer AN; Koolwijk P; Partanen TA; Alitalo K; Kroon ME; Kijlstra A; van Hinsbergh VW; Schlingemann RO
    Am J Pathol; 1999 Aug; 155(2):421-8. PubMed ID: 10433935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
    Bravo SB; García-Rendueles ME; Seoane R; Dosil V; Cameselle-Teijeiro J; López-Lázaro L; Zalvide J; Barreiro F; Pombo CM; Alvarez CV
    Clin Cancer Res; 2005 Nov; 11(21):7664-73. PubMed ID: 16278386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4.
    Broggini M; Marchini SV; Galliera E; Borsotti P; Taraboletti G; Erba E; Sironi M; Jimeno J; Faircloth GT; Giavazzi R; D'Incalci M
    Leukemia; 2003 Jan; 17(1):52-9. PubMed ID: 12529660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyrotropin dependent and independent thyroid cell lines selected from FRTL-5 derived tumors grown in nude mice.
    Ossendorp FA; Bruning PF; Schuuring EM; Van Den Brink JA; van der Heide D; De Vijlder JJ; De Bruin TW
    Endocrinology; 1990 Jul; 127(1):419-30. PubMed ID: 1694496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.
    Sato K; Yamazaki K; Shizume K; Kanaji Y; Obara T; Ohsumi K; Demura H; Yamaguchi S; Shibuya M
    J Clin Invest; 1995 Sep; 96(3):1295-302. PubMed ID: 7657804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.
    Ferrandina G; Melichar B; Loercher A; Verschraegen CF; Kudelka AP; Edwards CL; Scambia G; Kavanagh JJ; Abbruzzese JL; Freedman RS
    Cancer Res; 1997 Oct; 57(19):4309-15. PubMed ID: 9331092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
    Perrotte P; Matsumoto T; Inoue K; Kuniyasu H; Eve BY; Hicklin DJ; Radinsky R; Dinney CP
    Clin Cancer Res; 1999 Feb; 5(2):257-65. PubMed ID: 10037173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cells.
    Walls R; Thibault A; Liu L; Wood C; Kozlowski JM; Figg WD; Sampson ML; Elin RJ; Samid D
    Prostate; 1996 Sep; 29(3):177-82. PubMed ID: 8827086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
    Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
    J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Prostate; 1996 Mar; 28(3):182-94. PubMed ID: 8628721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
    Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma.
    Klein M; Vignaud JM; Hennequin V; Toussaint B; Bresler L; Plénat F; Leclère J; Duprez A; Weryha G
    J Clin Endocrinol Metab; 2001 Feb; 86(2):656-8. PubMed ID: 11158026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
    Lewy-Trenda I; Wierzchniewska-Ławska A
    Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of human thyroid endothelial cells.
    Patel VA; Logan A; Watkinson JC; Uz-Zaman S; Sheppard MC; Ramsden JD; Eggo MC
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E168-76. PubMed ID: 12388152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.